After Hours
$
75.55
Change
+0.28 +0.37%
Volume
Volume 831,994
Sep 21, 2023, 7:57 p.m.
Quotes are delayed by 20 min
Today's close
$ 75.82
$ 75.27
Change
-0.55 -0.73%
Day low
Day high
$75.22
$76.14

52 week low
52 week high
$61.45
$89.74

Market cap
$94.47B
Average volume
5.63M
P/E ratio
17.31
Rev. per Employee
$1.60M
EPS
4.35
Dividend
0.75
Div yield
3.99%
Ex dividend date
9/14/23
MarketWatch News on GILD
-
Gilead says FDA hits pause on study of leukemia treatment
- Eleanor Laise
-
Gilead Sciences Cuts Profit Forecast on Legal Settlement
- Josh Nathan-Kazis
-
Gilead Sciences’ stock slides 3.4% in after-hours trade
- Ciara Linnane
-
Gilead Sciences now sees full-year product sales of $26.3 bln to $26.7 bln vs. prior guidance of $26.0 bln to $26.5 bln
- Ciara Linnane
-
Gilead Sciences now sees full-year adj. EPS of 6.45 to $6.80 vs. $6.60 to $7.00 previously
- Ciara Linnane
-
Gilead Sciences Q2 revenue up 5% to $6.6 bln; FactSet consensus $6.5 bln
- Ciara Linnane
-
Gilead Sciences Q2 EPS 83 cents vs. 91 cents a year ago
- Ciara Linnane
-
Gilead Sciences Q2 adj. EPS $1.34; FactSet consensus $1.64
- Ciara Linnane
-
Earnings Galore, the Jobs Report, and More to Watch
- Nicholas Jasinski
-
- Janet H. Cho
- Loading more headlines...
Analyst Ratings
Other News on GILD
-
This Cancer Therapy is Lifesaving, but There Isn’t Enough of It
- The Wall Street Journal Interactive Edition
-
The Brash Strategy That Made Vivek Ramaswamy a Fortune
- The Wall Street Journal Interactive Edition
-
Gilead Sciences Is the Target of a Bizarre Legal Theory
- The Wall Street Journal Interactive Edition
-
Gilead Sciences Defeats the CDC
- The Wall Street Journal Interactive Edition
-
- Edgar Online - (EDG = 10Q, 10K)
-
These Drugs Are So Futuristic That Doctors Need New Training
- The Wall Street Journal Interactive Edition
-
Higher Rates Are Coming for U.S. Companies
- The Wall Street Journal Interactive Edition
-
First Drugs Facing Medicare Price Penalty Are Named
- The Wall Street Journal Interactive Edition
-
Seagen’s Cancer Therapy Is Making It a Takeover Target
- The Wall Street Journal Interactive Edition
-
- Edgar Online - (EDG = 10Q, 10K)
-
AQR CAPITAL MANAGEMENT LLC Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
VALUEWORKS LLC Buys 1, Sells 4 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of HealthInvest Partners AB
- GuruFocus.com
-
Top 5 4th Quarter Trades of Nan Shan Life Insurance Co., Ltd.
- GuruFocus.com
-
Top 5 4th Quarter Trades of Avalon Investment & Advisory
- GuruFocus.com
-
Caxton Associates Buys 4, Sells 1 in 4th Quarter
- GuruFocus.com
-
John Rogers Buys 3, Sells 2 in 4th Quarter
- GuruFocus.com
-
GLOBEFLEX CAPITAL L P Buys 4, Sells 1 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of KLCM Advisors, Inc.
- GuruFocus.com
- Loading more headlines...
Press Releases on GILD
-
Gilead Appoints Cindy Perettie Executive Vice President of Kite
- BusinessWire - BZX
-
Ensoma Closes Series B Extension, Bringing Total Round to $135 Million
- BusinessWire - BZX
-
Gilead Sciences to Present at Upcoming Investor Conferences
- BusinessWire - BZX
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com